Definium Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on signature page hereto)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Rob Barrow and Brandi L. Roberts as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and substitution, for him or her and in his or her name, place, and stead, in any and all capacities (including his/her capacity as a director and/or officer of Definium Therapeutics, Inc.) to sign any or all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents or any of them, or their, his, or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Robert Barrow | Chief Executive Officer and Director | February 26, 2026 |
| Robert Barrow | (Principal Executive Officer) | |
| /s/ Brandi L. Roberts | Chief Financial Officer | February 26, 2026 |
| Brandi L. Roberts | (Principal Financial Officer and Principal Accounting Officer) | |
| /s/ Carol Vallone | Director | February 26, 2026 |
| Carol Vallone | ||
| /s/ David Gryska | Director | February 26, 2026 |
| David Gryska | ||
| /s/ Roger Crystal | Director | February 26, 2026 |
| Roger Crystal, MD | ||
| /s/ Andreas Krebs | Director | February 26, 2026 |
| Andreas Krebs | ||
| /s/ Roger Adsett | Director | February 26, 2026 |
| Roger Adsett | ||
| /s/ Suzanne Bruhn | Director | February 26, 2026 |
| Suzanne Bruhn, PhD | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.